Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof
Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.
1. A skin-whitening method, comprising:
administering to a subject (2R/S,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid.
2. A skin-whitening method, comprising:
administering to a subject a compound represented by Formula 14 below:
wherein R 1 and R 2 are identical to each other, and are any one of OH and OAc.
3. The skin-whitening method of claim 2 , wherein the compound is selected from the group consisting of (2R/S,4R)-methyl 2-(3,4-dihydroxyphenyl)thiazolidine-4-carboxylate (Compound 104); and 4-((2R/S,4R)-4-(methoxycarbonyl)thiazolidin-2-yl)-1,2-phenylene diacetate (Compound 105).
4. A skin-whitening method, comprising:
administering to a subject a compound represented by Formula 15 below:
wherein the dotted line (represented by ‘---’) indicates a double bond, R 1 is any one of hydrogen and methyl, and two substitutes selected from R 2 through R 4 are identical to each other and the identical substitutes are any one of OH and OAc and the other one is hydrogen.
5. The skin-whitening method of claim 4 , wherein the compound is selected from the group consisting of 2-(2,4-dihydroxyphenyl)thiazol-4-carboxylic acid (Compound 101); and 4-(4-(methoxycarbonyl)thiazol-2-yl)-1,2-phenylene diacetate (Compound 103).